Acromegaly Completed Phase 4 Trials for Dopamine (DB00988)

Also known as: Acromegalic / Acromegaly (disorder)

Indication	Status	Phase
DBCOND0000951 (Acromegaly)	Completed	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00595140	Acute Application of Pegvisomant and Octreotide in Acromegaly	Treatment	Cabergoline (DB00248) Dopamine (DB00988) Octreotide (DB00104) Pegvisomant (DB00082) Somatostatin (DB09099)